Navigation Links
Joint Commission Alert: Stop Bad Behavior Among Health Care Professionals
Date:7/9/2008

commission.org/" target="_new">http://www.jointcommission.org/).

Founded in 1951, The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through the provision of health care accreditation and related services that support performance improvement in health care organizations. The Joint Commission evaluates and accredits more than 15,000 health care organizations and programs in the United States, including more than 8,000 hospitals and home care organizations, and more than 6,300 other health care organizations that provide long term care, assisted living, behavioral health care, laboratory and ambulatory care services. The Joint Commission also accredits health plans, integrated delivery networks, and other managed care entities. In addition, The Joint Commission provides certification of disease-specific care programs, primary stroke centers, and health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at http://www.jointcommission.org.


'/>"/>
SOURCE The Joint Commission
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Chicago-Area Radiation Oncology Facility
2. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
3. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
4. 3rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide, Inc.
5. World Renowned Hand Surgeon Helps Patients Conquer Joint Discomfort Naturally
6. Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals
7. Joint distraction promotes structural repair in patients with severe knee osteoarthritis
8. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
9. Authentidate and EncounterCare Form ExpressMD Solutions Joint Venture to Provide Telehealth Vital Signs Monitoring Systems Designed to Improve Chronic Illness Care for Patients
10. Meniscal damage and joint malalignment predictors of cartilage loss
11. Nutrition 21 Launches Iceland Health(R) Cholesterol Health and Iceland Health(R) Joint Relief Plus SLEEP Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
... is not widely prescribed by the physicians to tho...tients with abnormal heart rhythm. They are less c...ates among them are the highest. In case of elders..., atrial fibrillation, are not prescribed warfarin...
... reducing the bad cholesterol. For example food li...anadian researchers said that by combining these f...ople should go in for such diet as they are at a h... These diets reduce the bad cholesterol (LDL) as e...
... a common feature in the hill state of Himachal Pr...t every year on an average//, with the gender rati...cking factor is that despite such unchecked preval... convicted so far. The hill state of Himachal Pra...
...spread of HIV/AIDS, that has been haunting Papua N...cided to contribute $34 million//. PNG has the hig.... The health minister, Dr Puka Temu who is worki... Prime Minister has welcomed the initiative. He fu...
Other Medicine News:Health News:Warfarin the Not So Popular Drug for Stroke 2Health News:Choose Foods That Keep Bad Cholesterol at Bay 2Health News:Female Ratio Drops Alarmingly In Himachal Due To Feticides 2
(Date:10/2/2008)...XFORD, England, October 2 /- Circassi...ed on the fields of allergy and critical,care, tod...cal study of its,ToleroMune(R) technology in the f...results achieved in an earlier phase II study, whi... the ToleroMune approach to allergy,desensitizatio...
(Date:10/1/2008)...AMBRIDGE, Mass., Oct. 1 /- Ironwood P... $50 million in a private equity financing.,This c...se 3 development,program evaluating linaclotide fo...onstipation (IBS-C) and chronic constipation (CC),...covered drug candidates, and to,expand commercial ...
(Date:10/1/2008)...ALIFAX, Oct. 1 / ImmunoVaccine Techno...DepoVax(TM) is showing positive,pre-clinical resul...tic,cancer and several infectious disease vaccine ...nted October 4th at the Ehrlich II conference in,G... will also be reporting,on the capabilities of IVT...
(Date:10/1/2008)...nces in diagnostics and genetic testing give women... risks, DAYTON, Ohio, Oct. 1 /- Ac...p (2007), an estimated 182,460 new cases of breast...8. And while screening,programs are resulting in t...e easily and successfully treated, breast cancer c...
Breaking Medicine Technology:Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 3ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4Study reveals surprising details of the evolution of protein translation 4435 1Study reveals surprising details of the evolution of protein translation 4435 2AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 1AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 2AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 3AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 4Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 1Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 2Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 4Temple Fox Chase and Geisinger create Keystone Institute for Translational Medicine 25344 1Temple Fox Chase and Geisinger create Keystone Institute for Translational Medicine 25344 2
...ed for continuous, random access operation, the El...rge volume laboratories that want to maximize prod...mplicity, flexibility and Stat capabilities of the...e changing needs of an aggressive laboratory testi...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t
Sample throughput of up to 80 tests per hour (4 modules). Low maintenance requirements. Continuous random access. 25 - 100 channels on board. 1008 tests or 6 hours of walkaway operation.
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications.
Medicine Products: